A Novel ATXN7L3 De Novo Variant Underlies Harel‐Tora Neurodevelopmental Syndrome ( HATONS ) With Pre‐Axial Polydactyly
Clinical Genetics · 2026-07 · 110 (1) · 96-101
DOI: 10.1111/cge.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 27.02.2026. Verfasst von Muhammad Umair und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sci…. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Polydactyly, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: KAIMRC, Functional Characterization of Genes Associated with Neurodevelopmental Disorders, King Abdullah International Medical Research Center.
Abstract (Originalsprache)
Cellular homeostasis is maintained by deubiquitination, which plays critical roles in DNA damage repair, cell cycle progression, signal transduction, transcriptional regulation, and autophagy. The deubiquitination (DUB) module within the Spt‐Ada‐Gcn5 acetyltransferase (SAGA) complex is encoded by the ATXN7L3 gene. Disease‐causing variants in ATXN7L3 have been associated with an autosomal dominant neurodevelopmental disorder characterized by global developmental delay, hypotonia, speech impairment, and distinctive facial dysmorphism, known as Harel‐Tora neurodevelopmental syndrome (OMIM #621377). In the present study we used whole‐genome sequencing (WGS), followed by Sanger sequencing, to identify the disease‐causing genetic variant. WGS identified a novel de novo nonsense variant, c.236G>A (p.Trp79*), in the exon 4 of the ATXN7L3 gene (NM_001382309.1) located on chromosome 17q21.31, segregating perfectly with the disease phenotype. Furthermore, RT‐qPCR revealed a marked reduction in ATXN7L3 transcript levels in the affected individual, supporting its pathogenicity. 3D protein modeling of the mutated ATXN7L3 protein revealed substantial distortions in key secondary structural elements and loss of the C‐terminal of ATXN7L3. The present study expands the mutational spectrum of the ATXN7L3 gene associated with HATONS, and helps to provide accurate genetic counseling. This will help in the management of future pregnancies within the affected family.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs (MNGH), Riyadh, Saudi…
- Department of Biosciences, COMSATS University, Islamabad, Pakistan.
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies (DiSTABiF), University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Förderung
- KAIMRC, Functional Characterization of Genes Associated with Neurodevelopmental Disorders
- King Abdullah International Medical Research Center
Zitieren
APA
Umair, M., Ahmed, Z., Mahmood, A., Khan, H., Khan, M. J., & Ali, R. H. (2026). A Novel ATXN7L3 De Novo Variant Underlies Harel‐Tora Neurodevelopmental Syndrome ( HATONS ) With Pre‐Axial Polydactyly. Clinical Genetics, 110(1), 96-101. https://doi.org/10.1111/cge.70156
Vancouver
Umair M, Ahmed Z, Mahmood A, Khan H, Khan MJ, Ali RH. A Novel ATXN7L3 De Novo Variant Underlies Harel‐Tora Neurodevelopmental Syndrome ( HATONS ) With Pre‐Axial Polydactyly. Clinical Genetics. 2026;110(1):96-101. doi:10.1111/cge.70156
BibTeX
@article{Umair2026,
author = {Umair, Muhammad and Ahmed, Zaheer and Mahmood, Arif and Khan, Hammal and Khan, Muhammad Jawad and Ali, Raja Hussain},
title = {A Novel ATXN7L3 De Novo Variant Underlies Harel‐Tora Neurodevelopmental Syndrome ( HATONS ) With Pre‐Axial Polydactyly},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {1},
pages = {96--101},
doi = {10.1111/cge.70156}
}
EUVIMED